Newron Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	59.54	51.39	6.79	5.95	5.76	5.26	Upgrade
Other Revenue	0.35	-	2.26	0.14	-	-	Upgrade
Revenue	59.88	51.39	9.06	6.09	5.76	5.26	Upgrade
Revenue Growth (YoY)	759.13%	467.41%	48.62%	5.76%	9.59%	-25.29%	Upgrade
Gross Profit	59.88	51.39	9.06	6.09	5.76	5.26	Upgrade
Selling, General & Admin	11.41	11.58	7.53	7.39	7.39	8.47	Upgrade
Research & Development	13.27	13.64	13.15	12.01	10.73	14.85	Upgrade
Operating Expenses	24.68	25.22	20.69	19.4	18.12	23.32	Upgrade
Operating Income	35.2	26.17	-11.63	-13.3	-12.36	-18.07	Upgrade
Interest Expense	-4.4	-4.35	-4.17	-3.95	-2.92	-2.24	Upgrade
Interest & Investment Income	0.4	0.14	0.18	0.06	0.05	0.06	Upgrade
Currency Exchange Gain (Loss)	-0.11	-0.1	-0.07	0.12	0.2	-0.17	Upgrade
Other Non Operating Income (Expenses)	-0.21	-0.47	-0.51	-0.4	0.13	0.79	Upgrade
EBT Excluding Unusual Items	30.88	21.39	-16.2	-17.47	-14.88	-19.62	Upgrade
Pretax Income	30.88	21.39	-16.2	-17.47	-14.88	-19.62	Upgrade
Income Tax Expense	5.55	5.55	0.02	0.02	0.02	1.38	Upgrade
Net Income	25.33	15.84	-16.22	-17.49	-14.9	-21	Upgrade
Net Income to Common	25.33	15.84	-16.22	-17.49	-14.9	-21	Upgrade
Shares Outstanding (Basic)	19	19	18	18	18	18	Upgrade
Shares Outstanding (Diluted)	21	21	18	18	18	18	Upgrade
Shares Change (YoY)	16.86%	15.30%	-	-	-	-	Upgrade
EPS (Basic)	1.31	0.85	-0.91	-0.98	-0.84	-1.18	Upgrade
EPS (Diluted)	1.19	0.77	-0.91	-0.98	-0.84	-1.18	Upgrade
Free Cash Flow	24.53	-17.63	-10.15	-11.11	-11.47	-15.62	Upgrade
Free Cash Flow Per Share	1.15	-0.86	-0.57	-0.62	-0.64	-0.88	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	58.78%	50.93%	-128.40%	-218.28%	-214.46%	-343.59%	Upgrade
Profit Margin	42.30%	30.83%	-179.13%	-287.05%	-258.61%	-399.35%	Upgrade
Free Cash Flow Margin	40.97%	-34.30%	-112.08%	-182.31%	-198.98%	-297.11%	Upgrade
EBITDA	35.21	26.2	-11.49	-13.27	-12.31	-17.99	Upgrade
EBITDA Margin	58.81%	50.98%	-126.89%	-217.67%	-213.64%	-	Upgrade
D&A For EBITDA	0.01	0.02	0.14	0.04	0.05	0.07	Upgrade
EBIT	35.2	26.17	-11.63	-13.3	-12.36	-18.07	Upgrade
EBIT Margin	58.78%	50.93%	-128.40%	-218.28%	-214.46%	-	Upgrade
Effective Tax Rate	17.98%	25.95%	-	-	-	-	Upgrade
Revenue as Reported	59.88	51.39	9.06	6.09	5.76	5.26	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.